
Venozap 75 ER Tablet
Marketer
Doxis Laboratories
Salt Composition
Venlafaxine (75mg)
Overview Venozap 75 ER Tablet
AnxioZap 75 Extended-Release tablets treat anxiety and depressive disorders. This medication modifies brain chemistry, alleviating symptoms like agitation, edginess, poor focus, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take AnxioZap 75 ER with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon remembering; do not skip doses and complete the prescribed course, even with symptom improvement. Abrupt cessation is risky and may intensify symptoms. Possible side effects include queasiness, vomiting, sleeplessness, reduced appetite, increased anxiety, bowel irregularity, excessive sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks needing alertness until its effects are known. Most side effects are temporary and self-limiting. Consult your doctor if side effects persist or are bothersome. Before starting AnxioZap 75 ER, inform your physician of any kidney, heart, or liver problems, or a history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor immediately.
Primary Ingredients of Venozap 75 ER Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Venozap 75 ER Tablet
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Venozap 75 ER Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Venozap 75 ER Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Venozap 75 ER Tablet:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Venozap 75 ER Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Venozap 75 ER Tablet whole; avoid chewing, crushing, or fracturing it. Take this medication with food.
How Venozap 75 ER Tablet works:
Venozap 75 ER Tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Venozap 75 ER Tablet and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Venozap 75mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Venozap 75 mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant. Infants should be observed for drowsiness and appropriate weight increase.
DrivingUNSAFE
Driving ability may be impaired by Venozap 75 ER Tablet side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving capabilities.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Venozap 75 ER Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Venozap 75 ER tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Venozap 75 ER Tablet :
Should you forget a Venozap 75 ER Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Venozap 75 ER Tablet
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience and Central Nervous System |
| Behavior Class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
